Research on Project Scope Management of New
Drug Technology Transfer

Asina Journal Of Social Pharmacy

Previous Articles Next Articles

Research on Project Scope Management of New Drug Technology Transfer

Li Wei, Xing Hua*

1.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China; 2.North China Pharmaceutical Hua Sheng Co., Ltd., Shijiazhuang 052160, China

Online:2018-03-20 Published:2018-06-05
Contact: Xing Hua, master’s supervisor. Major research area: new drug development project management, pharmaceutical policy and management. Tel.: 13504908295, E-mail: gsglyxh@126.com.

Abstract

Abstract: Objective To apply project management concept and methods to new drug technology transfer projects so as to improve the success rates and efficiency of new drug technology transfer projects between drug R&D institutions and pharmaceutical manufacturers or among pharmaceutical manufacturers. Methods The theories and methods of project scope management, combined with management practices of new drug technology transfer projects were used to explain the process and working procedures of its management. Results and Conclusion Project scope management is not only the core of new drug technology transfer projects, but also the key to the success of new drug technology transfer.

Key words: new drug, technology transfer project, scope management

Li Wei, Xing Hua. Research on Project Scope Management of New Drug Technology Transfer[J]. Asina Journal Of Social Pharmacy.

Trendmd

[1]	Lan Yipeng, Huang Zhe. Real-World Evidence Supporting New Drug Review and Approval in European Union and Its Enlightenment to China [J]. Asian Journal of Social Pharmacy, 2021, 16(3): 203-208.
[2]	Bu Hemeng, Xue Aoming, Zhang Fang. Literature Review on the Development of New Drugs Based on TRIZ [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 60-67.
[3]	Wang Wanting, Xing Hua. Application Research of Earned Value Management in New Drug Research and Development Projects [J]. Asian Journal of Social Pharmacy, 2020, 15(1): 16-21.
[4]	Liu Dandan, Chen Yuwen. Analysis of New Drug Registration for Biological Products from 2010 to 2015 in China [J]. Asina Journal Of Social Pharmacy, 2017, 12(2): 57-63.
[5]	ZHANG Xing;LIAN Gui-yu;CHEN Yu-wen. Risk Aversion in New Drug Research and Development Market [J]. , 2014, 9(3): 124-127.
[6]	CUI Jing;CHEN Yu-wen. New Drug Application Approval in China 2009-2012 [J]. , 2013, 8(4): 258-261.
[7]	ZHAO Wei-guo;RUI Hua-yi;SUN Li-hua. Research on Pharmaceutical Industry Cluster’s Innovation Performance from Cultural Perspective [J]. , 2013, 8(1): 30-33.
[8]	WANG Yong-bao;XU Huai-fu. Reflections on Bringing Project Management into the Process of New Drug Research and Development [J]. , 2010, 5(2): 91-94.
[9]	YANG Bo;HUANG Tai-kang. Funding Sources of New Drug Research and Development in USA and Its Enlightenment to China [J]. , 2010, 5(1): 1-6.
[10]	XING Hua;LI Ye;SHI Xue;ZHOU Zheng. Analysis of the Stakeholders and Their Effects on R&D of New Drugs [J]. , 2009, 4(2): 77-80.
[11]	ZHANG Jie;HUANG Tai-kang . On China’s Pharmaceutical Market in the International Environment [J]. , 2008, 3(2): 74-77.
[12]	LIAN Gui-yu;HUANG Tai-kang. Research and Development of New Drugs in China: Problems and Reasons [J]. , 2008, 3(1): 20-24.
[13]	SHEN Han;XU Huai-fu. Discussion on the Patent Linkage Problems in Drug Registration [J]. , 2008, 3(1): 15-19.
[14]	XING Hua;LI Ye;YAO Jian-hua;LIU Xiao-ting. Management of Human Resources in New Drug Research and Development [J]. , 2007, 2(3): 85-89.
[15]	FAN Ming-jie;LIAN Gui-yu. Developing Strategies for New Drug Research in China in the New Situation [J]. , 2007, 2(3): 113-117.

Asian Journal Of Social Pharmacy

Research on Project Scope Management of New Drug Technology Transfer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments